Press release
After H. pylori is eradicated, invasive gastric cancer patterns
Helicobacter pylori
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72885
For decades, triple therapy (proton pump inhibitor + clarithromycin + amoxicillin/metronidazole) has been the gold standard. However, rising antibiotic resistance, particularly to clarithromycin, is driving innovation toward novel regimens, diagnostics, and vaccines. Increased awareness, advancements in molecular diagnostics, and expanding therapeutic pipelines are expected to transform the H. pylori market in the coming decade.
In 2024, the global H. pylori market is valued at USD 4.9 billion and is projected to reach USD 7.8 billion by 2034, growing at a CAGR of 4.7%.
Market Overview
• Market Size 2024: USD 4.9 billion
• Forecast 2034: USD 7.8 billion
• CAGR (2025-2034): 4.7%
Key Drivers
• High global prevalence of H. pylori infections.
• Rising incidence of gastric cancer linked to untreated infections.
• Growing antibiotic resistance fueling demand for novel therapies.
• Increasing availability of rapid diagnostic tests.
• Government and NGO-led awareness initiatives for early detection.
Key Challenges
• High rates of treatment failure due to resistance.
• Limited availability of alternative antibiotics in some regions.
• Lack of vaccines despite years of research.
• Regional disparities in diagnosis and treatment access.
Leading Players
Pfizer, Novartis, AstraZeneca, GlaxoSmithKline, Takeda, Abbott Laboratories, RedHill Biopharma, Phathom Pharmaceuticals, Cipla, and Lupin.
Segmentation Analysis
By Treatment Type
• Triple Therapy
• Quadruple Therapy
• Sequential & Concomitant Therapies
• Novel Antibiotics (rifabutin, vonoprazan-based regimens)
• Vaccines (in development)
By Diagnostic Method
• Urea Breath Test
• Stool Antigen Test
• Serology
• Molecular Diagnostics
By End User
• Hospitals & Gastroenterology Clinics
• Diagnostic Laboratories
• Research & Academic Institutes
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Summary:
Triple and quadruple therapy regimens remain the mainstay, but treatment failures are increasing due to resistance. Novel regimens (such as vonoprazan-based therapies) and improved molecular diagnostics are expected to drive future growth.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72885/helicobacter-pylori-market
Regional Analysis
• North America
Significant market share due to advanced diagnostics, strong healthcare systems, and FDA approvals of novel regimens.
• Europe
High adoption of quadruple therapies and widespread screening programs, with Germany, France, and the UK leading.
• Asia-Pacific
Largest patient pool and fastest-growing region, as H. pylori prevalence is highest in China, India, and Southeast Asia. Increasing investments in diagnostics and access to therapies are driving demand.
• Middle East & Africa
High infection prevalence but limited access to advanced diagnostics and therapies. Gradual improvements driven by public health programs.
• Latin America
Brazil and Mexico dominate, with growing diagnostic access and integration of novel therapies.
Summary:
Asia-Pacific represents the largest and fastest-growing H. pylori market, while North America and Europe lead in the adoption of advanced therapies and diagnostics.
Market Dynamics
Growth Drivers
1. Rising global prevalence of H. pylori infection.
2. Increasing link to gastric cancer driving early intervention.
3. Advances in rapid and molecular diagnostic methods.
4. Expansion of new therapeutic regimens beyond clarithromycin-based triple therapy.
5. Public health initiatives promoting awareness and eradication.
Challenges
• Antibiotic resistance undermining standard therapies.
• Limited access to affordable diagnostics in low-income regions.
• Slow progress in vaccine development.
• Variable adherence to treatment regimens reducing success rates.
Latest Trends
• Adoption of vonoprazan-based triple and quadruple therapies with higher eradication rates.
• Increased use of molecular resistance testing for personalized treatment.
• Ongoing research into therapeutic and prophylactic vaccines.
• Integration of point-of-care diagnostic devices in primary care.
• Growing role of digital health platforms for patient monitoring and treatment adherence.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72885
Competitor Analysis
Key Players
• Pfizer
• Novartis
• AstraZeneca
• GlaxoSmithKline
• Takeda
• Abbott Laboratories
• RedHill Biopharma
• Phathom Pharmaceuticals
• Cipla
• Lupin
Competitive Landscape
The market is moderately consolidated, with global players like Takeda, Pfizer, and AstraZeneca leading in therapy portfolios. Emerging biotech companies such as RedHill Biopharma and Phathom are driving innovation with next-generation regimens. Competition is focused on overcoming resistance, improving eradication rates, and advancing vaccine development.
Conclusion
The H. pylori market is entering a new growth phase, fueled by rising antibiotic resistance and strong demand for advanced therapies and diagnostics. Valued at USD 4.9 billion in 2024, the market is projected to reach USD 7.8 billion by 2034, expanding at a CAGR of 4.7%.
Future opportunities lie in the commercialization of vonoprazan-based regimens, vaccine development, and improving diagnostic access in high-prevalence regions. Companies that combine innovation with affordability and global access strategies will be best positioned to lead in this evolving market.
This report is also available in the following languages : Japanese (ヘリコバクター・ピロリ), Korean (헬리코박터 파일로리), Chinese (幽门螺杆菌), French (Helicobacter Pylori), German (Helicobacter Pylori), and Italian (Helicobacter Pylori), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72885/helicobacter-pylori-market#request-a-sample
Our More Reports:
Europe Women's Digital Health Market
https://exactitudeconsultancy.com/reports/73697/europe-women-s-digital-health-market
Asia-Pacific Women's Digital Health Market
https://exactitudeconsultancy.com/reports/73698/asia-pacific-women-s-digital-health-market
Digital Twins in Healthcare Market
https://exactitudeconsultancy.com/reports/73699/digital-twins-in-healthcare-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release After H. pylori is eradicated, invasive gastric cancer patterns here
News-ID: 4205711 • Views: …
More Releases from Exactitude Consultancy
Peptide Drug Discovery Market to Reach USD 5.3 Billion by 2034, Growing at 12% C …
Introduction
Peptides - short chains of amino acids - bridge the gap between small molecules and large biologics, offering unique therapeutic potential. With high specificity, low toxicity, and excellent safety profiles, peptide-based drugs are emerging as powerful tools in oncology, metabolic diseases, infectious diseases, cardiovascular disorders, and rare conditions.
The peptide drug discovery market has gained momentum due to advances in synthetic chemistry, high-throughput screening, structure-based design, and peptide libraries. Supported by…
Coronavirus Preventive Vaccines Market to Reach USD 92.7 Billion by 2034, Growin …
Introduction
The COVID-19 pandemic reshaped global healthcare, placing coronavirus preventive vaccines at the center of scientific, political, and public health efforts. Within record time, multiple vaccines were developed, authorized, and distributed globally, saving millions of lives.
While the emergency phase of the pandemic has passed, the coronavirus preventive vaccines market continues to evolve, driven by the need for booster programs, variant-targeted vaccines, pan-coronavirus research, and preparedness for future outbreaks. With mRNA, viral…
Non-Viral Drug Delivery Systems Market to Reach USD 41.2 Billion by 2034
Non-viral drug delivery systems are rapidly emerging as a cornerstone of modern medicine, offering safe and effective alternatives to viral vectors for transporting therapeutic agents such as nucleic acids, proteins, peptides, and small molecules. These systems include lipid nanoparticles (LNPs), polymers, exosomes, dendrimers, and physical methods like electroporation, which have demonstrated significant potential in gene therapy, oncology, vaccines, and regenerative medicine.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72887
The…
Antibody Purification Services Market to Reach USD 4.59 Billion by 2034
Antibody purification is a critical process in the production of biologics, therapeutic antibodies, diagnostic reagents, and research tools. It involves the isolation of antibodies from complex mixtures, ensuring high purity, stability, and functionality for downstream applications. With the rising demand for monoclonal antibodies, biosimilars, and antibody-based diagnostics, contract purification services are becoming essential for pharmaceutical, biotechnology, and research institutions.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72889
Advances in chromatography…
More Releases for Helicobacter
Helicobacter Pylori Diagnostic Market Size to Expand Lucratively by 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Helicobacter Pylori Diagnostic Market Size, Share & Trends Analysis Report By Technology (Immunoassays, POC, Molecular Diagnostics), By End User (Hospitals, Diagnostics Laboratories, Clinics)- Market Outlook And Industry Analysis 2031"
The Global Helicobacter Pylori Diagnostic Market is estimated to reach over USD 994.69 million by 2031, exhibiting a CAGR of 6.20% during the forecast period.
Get Free Access…
Helicobacter Pylori Testing Market 2024 Size, Status and Global Outlook |
Helicobacter Pylori Testing Market Overview:
A lot of factors, such as geographic growth, segmentation, and market size by value and volume, are taken into account in the SkyQuest Technology Group research to provide a full and accurate analysis of the global Helicobacter Pylori Testing market. This outstanding research study was created specifically to provide the most latest data on significant aspects of the global Helicobacter Pylori Testing Industry. Numerous…
Helicobacter Pylori Diagnostic Market Research Report 2023 | InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Helicobacter Pylori Diagnostic Market Size, Share & Trends Analysis Report By Technology (Immunoassays, POC, Molecular Diagnostics), By End User (Hospitals, Diagnostics Laboratories, Clinics)- Market Outlook And Industry Analysis 2031"
The Global Helicobacter Pylori Diagnostic Market is estimated to reach over USD 994.69 million by 2031, exhibiting a CAGR of 6.20% during the forecast period.
Request…
Helicobacter Pylori Diagnostics Market Size - Forecast to 2026
The findings reviewed by GME stated that the Global Helicobacter Pylori Diagnostics Market would grow at a CAGR value of 7.4 percent from 2021 to 2026. With drastically increasing advancements and less complex diagnostic processes, the reliability and demand for helicobacter pylori diagnostics are increasing. Also, most developing countries have unsanitary water services and facilities, along with a lack of awareness about personal care; the helicobacter pylori bacterial infection is…
Helicobacter Pylori Testing Market: Competitive Dynamics & Global Outlook 2025
Market Research Report Store offers a latest published report on Helicobacter Pylori Testing Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Helicobacter Pylori Testing market will register a 7.5% CAGR in terms of revenue, the global market size will reach $ 781.6 million by 2025, from $ 586 million in…
Global Helicobacter Pylori Testing Market Growth 2019-2024
LP INFORMATION offers a latest published report on Helicobacter Pylori Testing Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Helicobacter Pylori Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.…
